Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Interferon beta treatment of multiple sclerosis increases serum interleukin-7.
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
Flupirtine as neuroprotective add-on therapy in autoimmune optic neuritis.
Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function.
Identification of naturally occurring Fatty acids of the myelin sheath that resolve neuroinflammation.
Risk factors for convertion to clinically defined multiple sclerosis after clinically isolated syndrome in a racially mixed Brazilian cohort.
Laquinimod in Relapsing-Remitting Multiple Sclerosis
Teriflunomide in multiple sclerosis: Added benefit not proven
Burden of neurological conditions in Canada.
Development of a recombinant immunotoxin for the immunotherapy of autoreactive lymphocytes expressing MOG-specific BCRs.
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
Switch to natalizumab vs fingolimod in active relapsing-remitting multiple sclerosis.
Altered intra- and interregional synchronization in relapsing-remitting multiple sclerosis: a resting-state fMRI study.
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.
Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance.
A silver lining of neuroinflammation: Beneficial effects on myelination.
Dimethyl fumarate inhibits the expression and function of hypoxia-inducible factor-1α (HIF-1α).
The absence of 25-hydroxyvitamin D3-1α-hydroxylase potentiates the suppression of EAE in mice by ultraviolet light.
Patient trial of immunization to treat Alzheimer’s disease begins at Cedars-Sinai
A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field.
Antagonism of histamine H4 receptor exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis.
The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis.
Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study.
Magnetic resonance imaging outcomes from a phase III trial of teriflunomide.
A study to evaluate the effect of ultrasound treatment on nodules in multiple sclerosis patients.

Pages